iMedicalApps
Friday, February 19, 2010
TBI Treatment with Progesterone Enters Phase III Trials
Progesterone for traumatic brain injury tested in phase III clinical trial 02/19/2010. Douglas Smith, MD, director of the Center for Brain Injury and Repair and professor of Neurosurgery at the University of Pennsylvania School of Medicine, will present information on the molecular mechanism at play in mild TBI (mTBI), commonly called concussions. Although mTBI affects over 1 million people each year in the United States, it is generally ignored as a major health issue. However, this 'mild' form of injury induces persisting neurological and cognitive problems in many of these patients, exacting an enormous emotional and financial toll on society. Emory University via Eurekalert!
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment